Neoantigen-Targeted ppDC vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Neoantigen-Targeted ppDC vaccine, covering 2026-02-17 to 2026-02-17. Get the full timeline:
Most recent: Clinical Trial Update: A Vaccine (Neoantigen-Targeted ppDC) for the Treatment of H3 G34-mutant Diffuse Hemispheric Glioma [Phase 1]